Variant report
Variant | nsv900280 |
---|---|
Chromosome Location | chr13:63841148-63899543 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PCDH20-6 | chr13:63886242-63886263 | XLOC_010640 |
2 | lnc-PCDH20-6 | chr13:63886242-63886263 | XLOC_010640 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142824376 | chr13:63853005-63853006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs298810 | chr13:63853023-63853024 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs564026486 | chr13:63853042-63853043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs184244428 | chr13:63853050-63853051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs532993850 | chr13:63853075-63853076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs372262948 | chr13:63853084-63853085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs147184121 | chr13:63853129-63853130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs75526904 | chr13:63853151-63853152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs530172247 | chr13:63853152-63853153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs563286919 | chr13:63853168-63853169 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs80090560 | chr13:63853174-63853175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs117373619 | chr13:63853961-63853962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs530727728 | chr13:63853983-63853984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs60070486 | chr13:63861420-63861421 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs533520338 | chr13:63861422-63861423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs71200449 | chr13:63861434-63861435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs139363607 | chr13:63861435-63861436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs57636073 | chr13:63861452-63861453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs74978598 | chr13:63861467-63861468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs190477627 | chr13:63861549-63861550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs34875477 | chr13:63861565-63861566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs193218160 | chr13:63861569-63861570 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs531086035 | chr13:63861574-63861575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs11839402 | chr13:63861656-63861657 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs372310875 | chr13:63861667-63861668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs201985166 | chr13:63861673-63861674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs566554766 | chr13:63861690-63861691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs371843962 | chr13:63861710-63861711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs546641612 | chr13:63861716-63861717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs185492723 | chr13:63861718-63861719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs139621083 | chr13:63861724-63861725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs189566963 | chr13:63861730-63861731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs368890814 | chr13:63861776-63861777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs2992169 | chr13:63861781-63861782 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs575424277 | chr13:63861790-63861791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs536141185 | chr13:63861813-63861814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs180869424 | chr13:63861819-63861820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs572876727 | chr13:63861861-63861862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs548998796 | chr13:63861887-63861888 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs9564020 | chr13:63861899-63861900 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs564935816 | chr13:63861909-63861910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs185846506 | chr13:63861938-63861939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs544320105 | chr13:63861965-63861966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530828586 | chr13:63861969-63861970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs116431022 | chr13:63861982-63861983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs9570815 | chr13:63861989-63861990 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs377037149 | chr13:63861991-63861992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs369278983 | chr13:63862089-63862090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs549262989 | chr13:63862127-63862128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs141869105 | chr13:63862128-63862129 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:63853000-63853200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr13:63853800-63854000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr13:63861400-63861800 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
4 | chr13:63861800-63862800 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
5 | chr13:63862200-63864800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr13:63862800-63863000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
7 | chr13:63864200-63864600 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
8 | chr13:63872600-63872800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr13:63873000-63873800 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr13:63873800-63874800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr13:63874800-63875800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr13:63881000-63882400 | Enhancers | Dnd41 | blood |
13 | chr13:63881400-63882000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
14 | chr13:63881800-63883000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
15 | chr13:63882600-63883000 | Active TSS | Osteobl | bone |
16 | chr13:63895400-63896400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
17 | chr13:63896400-63897400 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
18 | chr13:63897400-63897800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
19 | chr13:63897600-63898200 | Enhancers | Fetal Lung | lung |